Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ETRM [NASD]
EnteroMedics, Inc.
Index- P/E- EPS (ttm)-0.58 Insider Own30.99% Shs Outstand55.62M Perf Week18.82%
Market Cap56.18M Forward P/E- EPS next Y-0.33 Insider Trans15.01% Shs Float47.15M Perf Month17.44%
Income-24.41M PEG- EPS next Q-0.12 Inst Own48.39% Short Float5.01% Perf Quarter12.22%
Sales0.19M P/S295.66 EPS this Y31.06% Inst Trans-3.89% Short Ratio4.45 Perf Half Y-65.29%
Book/sh0.33 P/B3.06 EPS next Y21.40% ROA-84.49% Target Price2.63 Perf Year-67.52%
Cash/sh0.53 P/C1.91 EPS next 5Y-8.50% ROE-144.28% 52W Range0.81 - 4.40 Perf YTD-63.93%
Dividend- P/FCF- EPS past 5Y0.00% ROI-93.19% 52W High-76.59% Beta1.45
Dividend %- Quick Ratio67.26 Sales past 5Y- Gross Margin22.50% 52W Low27.16% ATR0.07
Employees32 Current Ratio70.23 Sales Q/Q-100.00% Oper. Margin-12410.56% RSI (14)59.87 Volatility11.44% 6.32%
OptionableYes Debt/Eq0.52 EPS Q/Q8.43% Profit Margin-12955.47% Rel Volume0.98 Prev Close1.01
ShortableYes LT Debt/Eq0.52 EarningsMay 01 Payout- Avg Volume530.96K Price1.03
Recom1.80 SMA2011.90% SMA5012.89% SMA200-55.38% Volume489,929 Change1.98%
29-Jun-12Initiated Northland Securities Outperform $4.50
09-Jan-09Downgrade Argus Hold → Sell
03-Jan-08Initiated Cowen & Co Neutral
22-May-13 08:00AM  EnteroMedics to Participate in the Craig-Hallum Annual Institutional Investor Conference Marketwired
08:00AM  EnteroMedics to Participate in the Craig-Hallum Annual Institutional Investor Conference Marketwire
21-May-13 02:29PM  4 Stocks Under $10 Spiking Higher at TheStreet
17-May-13 01:04PM  ENTEROMEDICS INC Financials EDGAR Online Financials +22.35%
09:49AM  J.C. Penney Reports Its Earnings, Amazon Faces British Parliament, and 3 More Hot Stocks at Wall St. Cheat Sheet
07:01AM  InPlay: EnteroMedics completes VBLOC therapy pre-PMA meeting with FDA; expects to submit PMA in Q2 2013; prepares for subsequent advisory panel review Briefing.com
07:01AM  EnteroMedics completes VBLOC therapy pre-PMA meeting with FDA theflyonthewall.com
07:00AM  EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDA Marketwired
07:00AM  EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDA Marketwire
12:28AM  ENTEROMEDICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; EDGAR Online
13-May-13 11:08PM  ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of S EDGAR Online
10-May-13 09:54AM  ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
01-May-13 01:50PM  EnteroMedics Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha -9.37%
10:02AM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07:07AM  Q1 2013 EnteroMedics Inc Earnings Release - Time Not Supplied CCBN
07:00AM  EnteroMedics Reports First Quarter 2013 Financial Results Marketwired
07:00AM  EnteroMedics Reports First Quarter 2013 Financial Results Marketwire
12:47AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
22-Apr-13 11:04AM  EnteroMedics to Host First Quarter 2013 Financial Results Conference Call and Provide Business Update Marketwired
11:04AM  EnteroMedics to Host First Quarter 2013 Financial Results Conference Call and Provide Business Update Marketwire
13-Mar-13 01:04PM  ENTEROMEDICS INC Financials EDGAR Online Financials
12-Mar-13 07:00AM  EnteroMedics to Present at 25th Annual Roth Capital Partners Conference Marketwired
07:00AM  EnteroMedics to Present at 25th Annual Roth Capital Partners Conference Marketwire
07-Mar-13 05:10PM  ENTEROMEDICS INC Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-13 08:20AM  EnteroMedics and Orexigen Therapeutics Look to Benefit as Medical Costs Associated With Obesity Surpasses Smoking Marketwired
08:20AM  EnteroMedics and Orexigen Therapeutics Look to Benefit as Medical Costs Associated With Obesity Surpasses Smoking Marketwire
05-Mar-13 09:52AM  A Look At 3 Obesity Stocks at Seeking Alpha
27-Feb-13 02:29PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11:15AM  EnteroMedics Announces Closing of $13 Million Public Offering of Common Stock and Warrants Marketwired
11:15AM  EnteroMedics Announces Closing of $13 Million Public Offering of Common Stock and Warrants Marketwire
26-Feb-13 09:43AM  EnteroMedics to Present at Cowen and Company 33rd Annual HealthCare Conference Marketwired
09:43AM  EnteroMedics to Present at Cowen and Company 33rd Annual HealthCare Conference Marketwire
22-Feb-13 05:13PM  ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a EDGAR Online -19.64%
09:11AM  InPlay: EnteroMedics priced an underwritten public offering of 13.77 mln shares of its common stock and warrants to purchase 5.508 mln shares of its common stock Briefing.com
09:08AM  EnteroMedics Announces Pricing of $13 Million Public Offering of Common Stock and Warrants Marketwired
09:08AM  EnteroMedics Announces Pricing of $13 Million Public Offering of Common Stock and Warrants Marketwire
06:03AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
21-Feb-13 06:17PM  InPlay: EnteroMedics announces proposed public offering of common stock and warrants Briefing.com
06:13PM  EnteroMedics Announces Proposed Public Offering of Common Stock and Warrants Marketwire
20-Feb-13 03:43PM  CFO Moves: Swisher Hygiene, EnteroMedics, Owens & Minor at The Wall Street Journal
08:24AM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
07:00AM  InPlay: EnteroMedics names Greg S. Lea Chief Operating Officer Briefing.com
07:00AM  EnteroMedics Names Greg S. Lea Chief Operating Officer Marketwire
15-Feb-13 07:00AM  The Five Dumbest Things on Wall Street This Week: Feb. 15 at TheStreet -7.63%
14-Feb-13 09:17AM  New Star Analyst Rankings for EnteroMedics Inc. StarMine
13-Feb-13 04:38PM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  EnteroMedics Reports Fourth Quarter 2012 Financial Results Marketwire
12-Feb-13 06:05AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11-Feb-13 06:15PM  Nasdaq stocks posting largest volume increases AP
12:50PM  EnteroMedics May Get Approval, But Will It Get Sales? at Seeking Alpha
03:19AM  Small Pharma Watch List: Week Of February 11th, 2013 at Seeking Alpha
09-Feb-13 05:48AM  [$$] Charting the Market at Barrons.com
08-Feb-13 06:03PM  Nasdaq stocks posting largest volume increases AP -55.63%
02:45PM  EnteroMedics shares plummet as obesity device doesn't work as well as hoped at bizjournals.com
02:13PM  EnteroMedics VBLOC Obesity Device Fails at Seeking Alpha
01:35PM  EnteroMedics falls 50 percent on weak study data AP
11:19AM  Fridays biggest gaining and declining stocks at MarketWatch
10:39AM  Fridays biggest gaining and declining stocks at MarketWatch
10:31AM  An Obesity Treatment Doomed for Failure? at Motley Fool
09:27AM  Stocks to Watch: EnteroMedics, LinkedIn, Nuance Communications at The Wall Street Journal
09:01AM  Fridays biggest gaining and declining stocks at MarketWatch
08:06AM  Fridays biggest gaining and declining stocks at MarketWatch
07:48AM  BRIEF-EnteroMedics drops 50 pct, device fails study at Reuters
06:11AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07-Feb-13 05:23PM  EnteroMedics Weight-Loss Device Is A Pulsing Placebo at TheStreet
04:09PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:01PM  InPlay: EnteroMedics' ReCharge trial demonstrates statistically significant weight loss in obesity but does not meet predefined efficacy endpoints Briefing.com
04:00PM  EnteroMedics' ReCharge Trial Demonstrates Statistically Significant Weight Loss in Obesity But Does Not Meet Predefined Efficacy Endpoints Marketwire
06-Feb-13 05:24PM  New Obesity Treatments: Analyzing Expected Patient Choices To Guide Investment Decisions at Seeking Alpha
08:00AM  EnteroMedics: Fat Zapper or Pulsing Placebo? at TheStreet
29-Jan-13 07:45AM  The Obesity Epidemic: EnteroMedics' New Treatment Approach at Seeking Alpha
28-Jan-13 09:20AM  Biopharma Catalyst Trades To Watch For This Week at Seeking Alpha +5.24%
24-Jan-13 04:31PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04-Jan-13 05:36PM  VIX - Options Volatility Sonar: Friday Recap at Seeking Alpha
19-Nov-12 07:00AM  EnteroMedics to Present at Canaccord Genuity 2012 Medical Technology and Diagnostic Forum Marketwire +9.29%
16-Nov-12 01:04PM  ENTEROMEDICS INC Financials EDGAR Online Financials +6.87%
15-Nov-12 07:00AM  EnteroMedics to Present at the Piper Jaffray 24th Annual Healthcare Conference Marketwire
13-Nov-12 04:34PM  ENTEROMEDICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08-Nov-12 04:34PM  ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online +5.47%
07-Nov-12 12:30PM  EnteroMedics Announces EMPOWER Trial Hypertension Data Presented at the American Heart Association's 2012 Scientific Sessions Marketwire
06-Nov-12 11:06AM  EnteroMedics to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Marketwire
25-Oct-12 09:46AM  New Star Analyst Rankings for EnteroMedics Inc. StarMine
24-Oct-12 07:07AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q3 2012 ENTEROMEDICS INC Earnings Release - Before Market Open CCBN
07:00AM  EnteroMedics Reports Third Quarter 2012 Financial Results Marketwire
17-Oct-12 11:36AM  EnteroMedics to Host Third Quarter 2012 Financial Results Conference Call and Provide Business Update Marketwire
04-Oct-12 05:21PM  ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
05:18PM  InPlay: EnteroMedics secures a $45 mln commited issuer managed equity financing facility with Terrapin Opportunity Briefing.com
05:15PM  EnteroMedics Secures a $45 Million Committed Issuer Managed Equity Financing Facility With Terrapin Opportunity, L.P. Marketwire
28-Sep-12 04:29PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Se EDGAR Online
20-Sep-12 09:25AM  EnteroMedics to Present at Craig-Hallum 3rd Annual Alpha Select Conference Marketwire
11-Sep-12 12:11PM  EnteroMedics to Participate in the Lazard Capital Markets Third Annual Medical Technology 1x1 Corporate Access Day Marketwire
12:11PM  EnteroMedics to Participate in the Lazard Capital Markets Third Annual Medical Technology 1x1 Corporate Access Day Marketwire
23-Aug-12 04:42PM  Health Care Sector Wrap at Fox Business +8.79%
16-Aug-12 01:04PM  ENTEROMEDICS INC Financials EDGAR Online Financials
08-Aug-12 04:32PM  ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
09:39AM  New Star Analyst Rankings for EnteroMedics Inc. StarMine
07-Aug-12 08:05AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2012 ENTEROMEDICS INC Earnings Release - Before Market Open CCBN
07:00AM  EnteroMedics Reports Second Quarter 2012 Financial Results Marketwire
EnteroMedics Inc., a development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. It is developing Maestro System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. The company is evaluating the Maestro System in human clinical trials in the United States, Australia, Mexico, Norway, and Switzerland. It has collaboration with Mayo Clinic for research and development of its products. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jansz Anthony P.DirectorFeb 27Buy0.95150,000142,500150,000Mar 01 04:03 PM
WHITEBOX ADVISORS LLC10% OwnerJun 27Sale3.2727,59990,2492,350,486Jun 27 07:02 PM
WHITEBOX ADVISORS LLC10% OwnerJun 26Sale3.168,10025,5962,378,085Jun 27 07:02 PM
WHITEBOX ADVISORS LLC10% OwnerJun 25Sale3.1411,80037,0522,386,185Jun 27 07:02 PM
WHITEBOX ADVISORS LLC10% OwnerJun 22Sale3.168,40026,5442,397,985Jun 25 04:58 PM
WHITEBOX ADVISORS LLC10% OwnerJun 21Sale3.1310,66533,3812,406,385Jun 25 04:58 PM